Muc4/sialomucin complex in the mammary gland and breast cancer.
about
Cripto: a tumor growth factor and moreA signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast.Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.Expression of Mucin 4 in leukoplakia and oral squamous cell carcinoma: An immunohistochemical study.ERBB2 juxtamembrane domain (trastuzumab binding site) gene mutation is a rare event in invasive breast cancers overexpressing the ERBB2 gene.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Management of ErbB2-positive breast cancer: insights from preclinical and clinical studies with lapatinib.Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer.MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreasMucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.HER2 therapy: molecular mechanisms of trastuzumab resistance.Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast CancerBCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinibResistance to Trastuzumab in Breast Cancer.Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1.MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDACResistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.Management of metastatic HER2-positive breast cancer progression after adjuvant trastuzumab therapy - current evidence and future trends.The Tn antigen-structural simplicity and biological complexity.Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.Mechanisms of tumor cell resistance to the current targeted-therapy agents.Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis.Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro.N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imagingSecretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression.Her-2 positive mucinous carcinoma breast cancer, case report.MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
P2860
Q24292346-11384E87-4B32-46A4-B7C7-B8588242108FQ27938083-B639518B-6DCD-411F-A19A-B0301AC84A9EQ30990417-14D2B87F-DA34-42A4-9F46-F4E022B3D0F5Q33785772-54767220-7DD2-42E0-8C21-B01F0C1B77EEQ33875241-1517A458-5021-49C9-AC8A-98187C571E96Q34008627-A72C2294-A83C-4F63-8EBF-F4ACF5919328Q34241118-165E0207-6C31-4443-848A-08E11E0EA1F2Q34255976-B0E65676-6F1B-4285-8910-639BE4A24AC8Q34423709-965939D6-1207-4624-8815-CDF3F2A2EBDEQ34428742-D8F03917-1501-4705-9EB0-CE42E1BB12E0Q34560967-ED313E5B-7C15-4E35-BA6C-E6DFCFC25293Q35591546-0C087B61-728D-48B8-83BF-74E5644C487FQ35633712-BA907297-4656-4436-94F7-11E50E935131Q35684440-310C4ED6-F691-4749-B1A4-EDC0EB5B7CC4Q36299102-6EE48B93-9B6E-4A24-A789-7DBDACBE394CQ36318226-9609F5C6-FC3E-4945-ACF3-B6B1B1A918C6Q36405312-A29EB2AD-2B02-4912-A9D5-E60A8CCB1ABBQ36486678-02DC9D13-8804-410F-9F9E-897A3E70EB21Q36545296-19CB670F-7301-4D9A-8453-725806700BA5Q36751896-D444554D-F445-43B2-8F6F-059A866E1413Q36858047-122E711A-A2D2-429A-BD38-B55A923C71D8Q37725973-C6546CD3-D9B5-4D58-A41C-E73D11A1CFEDQ37831859-BD4B21CA-AB0E-49E7-ABB1-A3F5E194EDC5Q38085215-A3B054E5-88F8-4E1F-89CD-EC11DD921A6AQ38104645-F80B61CB-41CF-4B2A-997B-73219F525E90Q38828353-96EE8037-29AF-4D56-A077-E4E2ADEBD5BCQ38901000-B12303E9-0625-4E6E-AE13-818459657A98Q39095816-7932474B-047A-445B-B75E-2D50A299C9C8Q39327827-F8CA40CF-C291-4CC1-9680-BC9B7CBAA907Q41347430-2496481C-A1F9-4F54-9A8A-AB3B5EAF2E98Q45240901-EB722185-E95A-4710-9C3F-EF690F78487AQ47558826-13F2AED5-0862-4579-89D1-6EDFA23B2AFBQ48276348-394075DE-ECEC-4066-BF6B-67D0BEDC125A
P2860
Muc4/sialomucin complex in the mammary gland and breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Muc4/sialomucin complex in the mammary gland and breast cancer.
@ast
Muc4/sialomucin complex in the mammary gland and breast cancer.
@en
Muc4/sialomucin complex in the mammary gland and breast cancer.
@nl
type
label
Muc4/sialomucin complex in the mammary gland and breast cancer.
@ast
Muc4/sialomucin complex in the mammary gland and breast cancer.
@en
Muc4/sialomucin complex in the mammary gland and breast cancer.
@nl
prefLabel
Muc4/sialomucin complex in the mammary gland and breast cancer.
@ast
Muc4/sialomucin complex in the mammary gland and breast cancer.
@en
Muc4/sialomucin complex in the mammary gland and breast cancer.
@nl
P2093
P356
P1476
Muc4/sialomucin complex in the mammary gland and breast cancer.
@en
P2093
Carraway CA
Carraway KL
Price-Schiavi SA
P2888
P304
P356
10.1023/A:1011327708973
P577
2001-07-01T00:00:00Z
P6179
1017534059